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Abstract
Glycoprotein B (gB) facilitates HCMV entry into cells by binding receptors and mediating
membrane fusion. The crystal structures of gB ectodomains from HSV-1 and EBV are available,
but little is known about the HCMV gB structure. Using multiangle light scattering and electron
microscopy, we show here that HCMV gB ectodomain is a trimer with the overall shape similar to
HSV-1 and EBV gB ectodomains. HCMV gB ectodomain forms rosettes similar to rosettes
formed by EBV gB and the postfusion forms of other viral fusogens. Substitution of several bulky
hydrophobic residues within the putative fusion loops with more hydrophilic residues reduced
rosette formation and abolished cell fusion. We propose that like gB proteins from HSV-1 and
EBV, HCMV gB has two internal hydrophobic fusion loops that likely interact with target
membranes. Our work establishes structural and functional similarities between gB proteins from
three subfamilies of herpesviruses.
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Introduction
Herpesviruses are a large and diverse family of dsDNA, enveloped viruses that cause
lifelong, latent infections. These viruses are classified into three subfamilies, alpha-, beta-,
and gamma-, based on their replication cycle, tropism, and other characteristics. Eight
herpesviruses from all three subfamilies are human pathogens. Human cytomegalovirus
(HCMV), a betaherpesvirus, is notable for its extremely high prevalence in the general
population as well as the ability to cause serious infections in neonates and the
immunocompromised (Colugnati et al., 2007).
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HCMV can infect a wide range of mammalian cells (Compton and Feire, 2007), which
correlates with its ability to infect most organs and tissues. This broad cellular tropism
suggests that HCMV may bind a number of receptors or a common surface molecule
(Compton and Feire, 2007). HCMV enters cells by fusing its envelope with either the
plasma membrane (fibroblasts) (Compton et al., 1992) or the endosomal membrane
(epithelial and endothelial cells) (Ryckman et al., 2006). HCMV initiates cell entry by
attaching to the cell surface heparan sulfate proteoglycans using envelope glycoprotein M
(gM) or gB (Boyle and Compton, 1998; Boyle et al., 1999). This step is followed by
interaction with cell surface receptors that trigger entry or initiate intracellular signaling
(Compton and Feire, 2007). HCMV has been reported to engage PDGFR (Soroceanu et al.,
2008) and cellular integrins (Feire et al., 2004b), probably through their interaction with gB
(Feire et al., 2004a; Soroceanu et al., 2008). In support of this, a disintegrin-like consensus
sequence, an integrin-binding motif, was recently identified within residues 92–111 of
HCMV gB (Feire et al., 2004a) and shown to interact with a β1 integrin domain (Feire et al.,
2010). EGFR, initially reported to be necessary for HCMV cell entry (Wang et al., 2003),
was subsequently shown not to be important for either viral entry or HCMV-induced
signaling (Isaacson et al., 2007).
Interaction of gB with PDGFR and integrins probably engages cellular signaling pathways
instead of directly participating in viral entry because gB expression does not interfere with
entry into either epithelial cells or fibroblasts (Ryckman et al., 2008). The entry receptor
function might instead be provided by gH/gL glycoprotein complexes. Different gH/gL
complexes are known to facilitate entry into epithelial cells, endothelial cells, or fibroblasts.
While entry into fibroblasts requires gH/gL heterodimer (Wille et al., 2010), entry into
epithelial and endothelial cells requires the pentameric complex gH/gL/UL128/UL130/
UL131 (or gH/gL/UL128-131) (Ryckman et al., 2006), in addition to gH/gL (Ryckman et
al., 2010; Wille et al., 2010). Expression of gH/gL/UL128-131 complex, but not gH/gL, in
epithelial cells causes cells to become resistant to HCMV infection (Ryckman et al., 2008),
which suggests that gH/gL/UL128–131 complex binds HCMV receptor on epithelial cells.
By contrast, HCMV infection of fibroblasts can be blocked by co-expression of gH/gL and
gO (Vanarsdall et al., 2011) but not gH/gL/UL128-131. Thus, different gH/gL complexes
engage distinct entry receptors on epithelial/endothelial cells and fibroblasts, but they have
not yet been identified.
Receptor engagement is followed by membrane fusion, a process mediated by gB and gH/
gL. Early antibody studies have supported critical roles for both gB and gH/gL in HCMV
entry (Britt, 1984; Cranage et al., 1986; Simpson et al., 1993; Urban et al., 1996). gB is
essential for entry and cell spread, as shown by studies on an HCMV gB-null mutant in
fibroblasts (Isaacson and Compton, 2009). gB and gH/gL are necessary and sufficient for
cell fusion (Vanarsdall et al., 2008) and thus constitute the “core fusion machinery” of
HCMV, which is conserved among other herpesviruses (Eisenberg et al., 2012). HCMV gB
and gH/gL can mediate fusion either in cis (from the same membrane) or in trans (from
opposing membranes) (Vanarsdall et al., 2008), which has also been observed for HSV-1
(Atanasiu et al., 2010). The precise fusion trigger in HCMV has not yet been identified.
Receptor binding by gH/gL/UL128-131 probably does not trigger fusion because the
expression of gH/gL/UL128–131 does not block cell fusion (Vanarsdall et al., 2008).
Alternatively, receptor binding by gH/gL/UL128-131 functions as a fusion trigger only
during endosomal entry but not entry at the plasma membrane or cell fusion.
Relatively little is known about the specific role of gB in HCMV entry and cell fusion apart
from its requirement for both processes and its engagement of cellular signaling receptors.
By contrast, more mechanistic details are available for homologous gB proteins from
HSV-1, an alphaherpesvirus, and EBV, a gammaherpesvirus. Crystal structures of gB from
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HSV-1 (Heldwein et al., 2006) and EBV (Backovic et al., 2009) revealed strong protein fold
similarities between the two ectodomains (Connolly et al., 2011) despite low sequence
identity (25.9%) and provided important functional insights. gB proteins are structurally
similar to the viral fusion proteins from unrelated viruses vesicular stomatitis virus G (VSV
G) and baculovirus gp64, both of which are necessary and sufficient for viral entry and cell
fusion. This structural similarity, in the absence of any sequence similarity, implicated gB as
the fusion protein of herpesviruses capable of undergoing large conformational changes to
effect fusion (Heldwein et al., 2006). Together, HSV-1 gB, EBV gB, VSV G, and gp64
formed a new class of viral fusion proteins, class III, that is distinct from class I, exemplified
by influenza hemagglutinin, and class II, represented by flavivirus envelope protein E
(Harrison, 2008; Steven and Spear, 2006).
Structural similarity with VSV G helped pinpoint the location of the two putative fusion
loops in HSV-1 gB (Heldwein et al., 2006). Mutations of specific residues in these loops
abolished fusion (Hannah et al., 2009; Hannah et al., 2007) as well as interaction with model
membranes (liposomes) (Hannah et al., 2009), providing biochemical and functional
evidence for the possible involvement of these residues in fusion, most likely in membrane
insertion. Hydrophobic residues in fusion loops in EBV gB were shown to be necessary for
fusion (Backovic et al., 2007a) and also responsible for the formation of rosettes by the
recombinant EBV gB ectodomain (Backovic et al., 2007b). Such rosette formation has been
observed with the ectodomains of several viral fusion proteins, e.g., influenza hemagglutinin
(Ruigrok et al., 1988) and SFV E1 (Gibbons et al., 2004) whereby the exposed hydrophobic
fusion peptides or loops interacted, causing aggregation. Finally, unlike gH/gL that can
participate in fusion as a soluble protein, gB has to be membrane anchored (Atanasiu et al.,
2010), which is consistent with it being a fusion protein. Taken together, these data support
the hypothesis that HSV-1 and EBV gB are viral fusion proteins.
By comparison, little structural and mechanistic information is available on HCMV gB. Its
ectodomain shares 24.2% sequence identity with HSV-1 gB and 30.3% with EBV gB.
Previously, the ectodomain of HCMV gB was expressed in insect cells and shown to be
proteolytically processed and to react with conformational antibodies (Carlson et al., 1997),
justifying its use in functional experiments. However, no additional structural
characterization has been carried out, and it remains unclear to what extent HCMV gB
resembles its alpha- and gammaherpesvirus counterparts.
Here we show that the HCMV gB ectodomain is a trimer with an overall architecture
resembling the ectodomains of HSV-1 and EBV gB, which supports the idea that gB
proteins from all three herpesvirus subfamilies share similar structures. The ectodomain of
HCMV gB forms rosette-like aggregates, similar to rosettes formed by the EBV gB
ectodomain. By generating and analyzing a homology model of HCMV gB ectodomain
based on HSV-1 gB structure (Heldwein et al., 2006), we identified four exposed
hydrophobic residues within the putative fusion loops, Y155, I156, Y157, and W240.
Substitution of these residues with their more hydrophilic HSV-1 counterparts reduced
rosette formation and abolished cell fusion. We propose that HCMV gB has two internal
hydrophobic fusion loops, functionally similar to those of HSV-1 and EBV gB, that are
required for membrane fusion. Together with the structural information, these results
support the hypothesis that gB is the fusion protein of HCMV. Our findings establish
structural and functional similarities between gB proteins from three different herpesvirus
subfamilies.
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Expression and purification of recombinant HCMV gB ectodomain
All gB ectodomain constructs were expressed in insect cells infected by recombinant
baculoviruses. Initially, three gB constructs were created, all encoding the mature
ectodomain of HCMV (strain AD169) gB, residues 25–706, with a honeybee melittin signal
sequence and either an N-terminal His6 tag, a C-terminal His6 tag, or no tag (Fig. 1). All
constructs lacked the hydrophobic membrane-proximal region, the transmembrane region,
and the cytoplasmic domain. HCMV gB residues 25–706 correspond to the HSV-1 gB
residues 31–730. Previously expressed version of the HCMV gB ectodomain, residues 1–
692, was shorter and contained a C-terminal His6 tag (Carlson et al., 1997) yet could not be
purified using metal affinity chromatography (Carlson et al., 1997). HCMV gB residue 692
corresponds to HSV-1 gB residue 715, which is buried in the crystal structure (Heldwein et
al., 2006; Stampfer et al., 2010), so a His6 tag immediately following this residue would not
be fully exposed. To avoid this problem, our constructs were extended to residue 706, which
corresponds to HSV-1 gB residue 730.
Initially, His6-tagged gB706 proteins were purified using metal affinity chromatography.
Due to poor protein purity and yield, we switched to immunoaffinity purification with the
mAb 27–39, which recognizes a conformational epitope within the oligomeric form of the
HCMV gB ectodomain (Britt and Vugler, 1992). Subsequent size-exclusion chromatography
yielded pure HCMV gB ectodomain (Fig. 2A). Purity and yield, ~10–20 μg from 1 liter of
insect cell supernatant, were highest with gB706-CHis6, and it was used in subsequent work.
HCMV gB is proteolytically processed into disulfide-linked N and C termini
HCMV gB contains a furin cleavage site, RTRR, residues 456–459 (Figs. 1 and 3). In cells
infected with HCMV or transfected with a plasmid encoding HCMV gB, the 160-kDa
precursor is cleaved into an N-terminal product of ~116 kDa and a C-terminal product of
~58 kDa, albeit incompletely (Britt and Vugler, 1989; Vey et al., 1995). gB incorporated
into HCMV virions is likewise incompletely processed (Britt, 1984). Since insect cells
express furin-like proteases (Cieplik et al., 1998), we tested if HCMV gB ectodomain
expressed in insect cells underwent proteolytic processing by analyzing purified gB706-
CHis6 protein by SDS-PAGE in the presence or absence of the reducing agent, beta-
mercaptoethanol (BME).
In the absence of BME, gB706-CHis6 migrated as a ~120–130 kDa band, consistent with a
monomer, as well as a higher MW species (discussed below) (Fig. 2A). In contrast, in the
presence of BME, we observed two additional bands migrating at ~70 kDa and ~35 kDa
(Fig. 2A). The ~35-kDa band reacted with a mAb 27–156 (Fig. 2A), which recognizes
antigenic domain 1 (AD-1) (Spaete et al., 1988), the dominant antibody-binding site within
residues 552–635 of HCMV gB (Britt et al., 2005; Wagner et al., 1992). Thus, the ~70 kDa
and the 35-kDa bands corresponded to the N- and C-terminal fragments, respectively. The
smaller size of the C-terminal fragment in the gB706-CHis6 relative to the virion gB is due
to the absence of residues 707–906 while the smaller size of the N-terminal fragment can be
explained by the presence of less complex carbohydrate chains that insect cells use to
modify glycoproteins (Jarvis, 2003). Similar results were previously obtained with HCMV
gB692-CHis6 expressed in TN5 insect cells (Carlson et al., 1997). The recombinant HCMV
gB ectodomain expressed in insect cells is processed similarly to the gB incorporated into
HCMV virions, although with a lower efficiency. Lower efficiency of furin cleavage,
probably due to low levels of endogenous furin, has been observed with other glycoproteins
expressed in insect cells (Cieplik et al., 1998).
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HCMV gB ectodomain forms rosette-like aggregates
Recombinant gB ectodomains from HSV-1 and EBV are trimeric (Backovic et al., 2009;
Heldwein et al., 2006). HCMV gB692-CHis6 was reported to migrate as a dimer on a mildly
denaturing SDS-PAGE (Carlson et al., 1997). Likewise, we found that under non-reducing,
mildly denaturing conditions, approximately half of gB706-CHis6 migrated as a high-
molecular-weight band (Fig. 2A). Under similar conditions, the trimeric HSV-1 gB
ectodomain also migrates as an apparent dimer (Silverman et al., 2010; Stampfer et al.,
2010). This seeming anomaly is probably due to incomplete denaturation, which precludes
accurate estimation of the molecular size based on electrophoretic mobility. Unfortunately,
we could not assess the oligomeric state of the HCMV ectodomain in solution using size-
exclusion chromatography because the protein aggregated and eluted as a broad double peak
near the void volume (Fig. 2B).
To gain insight into the nature of oligomerization and aggregation of the HCMV gB
ectodomain, we examined the purified gB706-CHis6 samples using negative-stain electron
microscopy (EM). We observed primarily long rods and three-armed particles (Fig. 2C),
plus occasional rosettes with 4 or 5 arms. The length of each arm in the three-armed
particles, 16.9 ± 1.3 nm (n=6), was consistent with the length of HSV-1 gB ectodomain
calculated from its atomic coordinates (16.7 nm) (Heldwein et al., 2006) or measured from
EM images (16.1 nm) (Stampfer et al., 2010). Thus, each arm was likely composed of
HCMV gB706-CHis6 ectodomain, such that the three-armed particle contained three
ectodomains. The long rods were 34.2 ± 1.5 nm (n=5) in length, approximately twice as
long as the HSV-1 gB ectodomain, and were likely formed by two HCMV gB ectodomains
joined end-to-end. The characteristic “crown” shape at the tip of each arm in the three-armed
particles and at both ends of the long rods (Fig. 2C) resembled the “crown” end of the
HSV-1 gB730 molecule (Fig. 2D) (Heldwein et al., 2006; Silverman et al., 2010; Stampfer
et al., 2010). Both three-armed particles and long rods appear to associate by the “base”
ends, which in HSV-1 and EBV gB contain the fusion loops.
Fusion loops (and fusion peptides) are important functional regions in viral fusion proteins.
Typically rich in aromatic and hydrophobic residues, fusion loops are thought to insert into
target cellular membranes during fusion. Exposed hydrophobic fusion loops in the
postfusion forms of several viral fusion proteins can lead to the formation of rosette-like
aggregates (Gibbons et al., 2004; Ruigrok et al., 1988). In these rosettes, ectodomains
associated by their fusion loop regions (Gibbons et al., 2004; Ruigrok et al., 1988). EBV gB
ectodomain also formed rosettes that depend on interactions between the hydrophobic fusion
loops (Backovic et al., 2007b). Specifically, replacement of hydrophobic residues
WY112–113 and WLIW193–196 in fusion loops 1 and 2 of EBV gB with their less
hydrophobic HSV-1 gB counterparts HR and RVEA, respectively, abolished rosette
formation (Backovic et al., 2007b) and allowed crystallization (Backovic et al., 2009). In
contrast to EBV gB, HSV gB ectodomain did not aggregate (Heldwein et al., 2006) (Fig.
2D); nevertheless, the fusion loops of HSV-1 gB enabled liposome association (Hannah et
al., 2009). Since HCMV gB rosette-like particles were reminiscent of the rosettes formed by
EBV gB ectodomain and by the ectodomains of other viral fusion proteins, we hypothesized
that the putative fusion loops of HCMV gB were involved in rosette formation.
Formation of HCMV gB rosette-like aggregates is mediated by hydrophobic residues
within the fusion loops
The putative fusion loops of HCMV gB, YAYIYT153–158 and GSTWLYRE237–244, contain
several hydrophobic residues (Figs. 3 and 4). To identify surface-exposed hydrophobic
residues within the fusion loops, we generated a homology model of HCMV gB ectodomain
(Fig. 4) using the structure of HSV-1 gB730 (Heldwein et al., 2006). Residues YIY155–157
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and W240 were prominently exposed on the surface of the HCMV gB706 homology model
(Fig. 4A). To determine their role in rosette formation, we substituted residues YIY155–157
and W240 with their less hydrophobic HSV-1 gB counterparts GHR and A, respectively
(Figs. 1 and 4B), generating gB706-4M mutant (Y155G/I156H/Y157R/W240A).
The gB706-4M mutant ectodomain was expressed and purified in the same way as the wt
gB706-CHis6, but its yield was significantly higher, ~500 μg from 1 liter of insect cells.
Like the wt ectodomain, the mutant migrated as an oligomer on a mildly denaturing SDS-
PAGE and was partially processed into disulfide-linked N- and C-terminal fragments (Fig.
5A). N-terminal sequencing of the C-terminal fragment revealed the sequence STSDNN,
which matched the sequence following the furin cleavage site. This result unequivocally
confirmed that the HCMV gB ectodomain was cleaved at the furin site during expression in
insect cells.
On a size-exclusion column, gB706-4M eluted as two peaks (Fig. 5B). Peak 1 eluted in the
void volume of the column and contained aggregated protein while peak 2 eluted in the
same volume as the monodisperse HSV-1 gB730 and likely contained the monodisperse
gB706-4M protein (Fig. 5B). In support of this, negative-stain EM revealed that peak 1
contained rosette-like aggregates, mostly long rods but also three-armed particles, plus an
occasional short rod (Fig. 5C). By contrast, peak 2 contained only short rods, 17.8 ± 0.8 nm
(n=4) in length, representing monodisperse gB706-4M ectodomains (Fig. 5C).
Thus, replacement of several hydrophobic residues in the putative fusion loop regions with
neutral or charged residues prevented aggregation of the HCMV gB ectodomain. This
finding confirmed that the rosette-like aggregates of HCMV gB were held together by
interactions between hydrophobic residues in the fusion loop regions.
Hydrophobic residues in fusion loops are necessary for cell fusion
The importance of residues Y155, I156, Y157, and W240 for rosette formation suggested
that they might be necessary for fusion. To evaluate their contribution to fusion directly, we
tested the gB-4M mutant in a cell fusion using an established adenovirus transduction assay
(Vanarsdall et al., 2008). The mutations were introduced into HCMV TR gB, generating
mutant gB-4M (Y156G/I157H/H158R/W241A, TR numbering). Unlike the WT HCMV TR
gB, the gB-4M mutant did not mediate any cell fusion of ARPE-19 cells in the presence of
gH/gL (Fig. 6A). Lack of fusion was not due to insufficient surface expression because
surface expression level of the gB-4M mutant was comparable to the expression level of the
WT HCMV TR gB, as detected by cell-based ELISA (Fig. 6B). The gB-4M mutant also
became largely endoglycosidase H resistant in a similar fashion to the WT gB (data not
shown), confirming that this mutant gB passed ER quality control. Thus, substitution of four
residues in the putative fusion loops abrogated fusion without affecting the expression or the
trafficking of the mutant to the cell surface. On the basis of these observations, we propose
that residues 153–158 and 237–244 constitute functional fusion loops in HCMV gB, with
residues Y155, I156, Y157, and W240 (AD169 numbering) likely playing important roles in
fusion.
HCMV gB ectodomain is a trimer
Monodisperse HCMV gB706-4M particles were very similar to those of trimeric HSV-1
gB730 in both their length and shape (Fig. 5D). Moreover, the mutant eluted in the same
volume as the HSV-1 gB730 on a size-exclusion column (Fig. 5B), suggesting that like
HSV-1 gB ectodomain, the HCMV gB ectodomain is trimeric.
To determine the oligomeric state of HCMV gB706-4M directly, we used multi-angle light
scattering (MALS). This technique is independent of molecular shape and can be used to
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determine molecular weight of non-globular proteins. HSV-1 gB730, a known trimer, was
used as a control. The precise molecular weights of the glycosylated HSV-1 gB730 and
HCMV gB706-4M polypeptides were determined by MALDI-TOF mass spectrometry. The
experimentally determined molecular weight of HSV-1 gB730 was 85.6 kDa, larger than
that calculated from its amino acid sequence 78.8 kDa due to glycosylation of 6 predicted N-
linked glycosylation sites (Fig. 3). The molecular weight of the HSV-1 gB730 ectodomain in
solution, as determined by MALS, was 266.1 kDa (Fig. 7A), which is consistent with a
trimer. The experimentally determined molecular weight of HCMV gB706-4M polypeptide
was 101.3 kDa, larger than that calculated molecular weight of 78.4 kDa. The difference of
22.9 kDa suggested that all 18 predicted N-linked glycosylation sites were glycosylated
(Fig. 3). The molecular weight of HCMV gB706-4M ectodomain in solution, as determined
by MALS, was 300.3 kDa (Fig. 7B), which corresponds to a trimer. Thus, the HCMV gB
ectodomain is a trimer like HSV-1 and EBV homologs.
Discussion
HCMV gB shares structural similarities with gB proteins from HSV-1 and EBV
gB is a key entry protein of HCMV, yet very little is known about its structure and its
specific role in HCMV entry. Here, we carried out a detailed biochemical characterization of
the HCMV gB ectodomain. The recombinant HCMV gB ectodomain expressed in insect
cells was proteolytically cleaved and glycosylated similarly to virion HCMV gB and was
used to investigate the structural and biochemical properties of HCMV gB. We obtained
direct evidence that HCMV gB ectodomain is a trimer and that its overall structure
resembles the ectodomains of HSV-1 and EBV gB. This novel finding demonstrates that
despite relatively low sequence identity, the three proteins share fundamentally similar
structures. More detailed structural comparisons await the crystal structure of HCMV gB.
HCMV gB has functional fusion loops
We found that HCMV gB ectodomain formed rosette-like aggregates associated by its
presumed fusion loop regions. By generating and analyzing a homology model of HCMV
gB706, based on the crystal structure of HSV-1 gB730 (Heldwein et al., 2006), we identified
several exposed hydrophobic residues in the putative fusion loops. Replacement of the most
prominently exposed residues Y155, I156, Y157, and W240 with their hydrophilic HSV-1
counterparts significantly decreased aggregation, suggesting that these residues confer the
ability to form rosettes on HCMV gB ectodomain. The propensity of HCMV gB ectodomain
to aggregate via its fusion loop regions resembles EBV gB and is consistent with both
proteins containing multiple hydrophobic residues within these loops. Due to aggregation of
the WT HCMV gB ectodomain, we were unable to test its ability to associate with
membranes or to evaluate the effect of fusion loop mutations on this ability. Instead, we
tested the importance of these four residues for cell fusion. The quadruple mutant gB-4M
was unable to mediate cell fusion despite adequate surface expression, confirming the
importance of mutated residues for fusion. Analogous substitutions within the fusion loops
of EBV gB eliminated rosette formation (Backovic et al., 2007b) and abrogated its fusion
activity (Backovic et al., 2007a). We propose that HCMV gB has two functional fusion
loops and that residues Y155, I156, Y157, and W240 are necessary for fusion. Future work
will assess individual contributions of these residues to fusion.
Possible role of hydrophobic residues in HCMV gB fusion loops in fusion
Fusion loops, found in class II and class III viral fusion proteins, are typically rich in
aromatic and hydrophobic residues. Fusion loops insert into and perturb the outer leaflet of
the target cellular membranes thereby facilitating membrane fusion. Aromatic residues are
thought to play an essential role in the destabilization of the outer leaflet because they
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position themselves at an interface between the hydrocarbon side chains and the polar head
groups. In VSV G, three aromatic residues in fusion loops are required for fusion (Sun et al.,
2008). The fusion loops of EBV gB contain four aromatic residues (Backovic et al., 2007a).
Residues W174 and Y179 within relatively hydrophilic fusion loops of HSV-1 gB are
critical for fusion (Hannah et al., 2007). Therefore, we anticipate that all aromatic residues
within HCMV gB fusion loops will be essential for fusion, likely for insertion into the target
membrane.
The recombinant HCMV gB ectodomain likely adopts the postfusion conformation
The conformation adopted by the recombinant gB ectodomains from HSV-1, EBV, and
HCMV probably represents the postfusion form. Indeed, the structures of HSV-1 and EBV
gB ectodomains more closely resemble the extended postfusion rather than the globular
prefusion structure of VSV G. Also, in both structures, the fusion loops are located in
proximity to the C termini leading into the transmembrane region, which is a typical feature
of the postfusion forms of all other fusion proteins. Therefore, we conclude that like HSV-1
and EBV gB, the HCMV gB ectodomain expressed in insect cells adopts the trimeric
postfusion conformation. Of course, the structure of the prefusion form of gB is necessary to
definitively confirm this. By analogy with other viral fusion proteins, gB is hypothesized to
undergo large-scale refolding during fusion, although evidence for refolding has not yet
been obtained. The recombinantly expressed gB ectodomain adopts the postfusion
conformation whereas on the viral envelope or on cell surface gB is presumably in its
prefusion conformation. Thus, any future work with the HCMV gB ectodomain should take
into account the fact that the conformation of the recombinantly expressed gB ectodomain
may differ from that of the full-length, membrane-bound gB.
gB is the likely fusion protein of HCMV
The most conserved among herpesvirus entry glycoproteins, gB is thought to be the fusion
protein of HSV and EBV. Here we showed that HCMV gB ectodomain shares overall
structure with the HSV-1 gB ectodomain and that several residues in its fusion loops
mediate rosette formation and are necessary for fusion. These results support the hypothesis
that gB is the fusion protein of HCMV. Taken together, our findings establish structural and
functional similarities between gB proteins from three different herpesvirus subfamilies.
Materials and Methods
Cloning and mutagenesis
To generate a HCMV gB ectodomain expression construct, DNA encoding the mature
ectodomain of HCMV (strain AD169) gB, residues 25–706, was amplified using forward
primer 5′-CGCGGATCCGTCTTCTAGTACTTCCCATGC-3′, BamHI site underlined, and
reverse primer 5′-CGCGGTACCTCAGGGCGGTAGCGGGTCGACTA-3′, KpnI site
underlined. The resulting PCR product was cloned into the BamHI and KpnI-digested
pFastBac1 vector (Invitrogen) modified to contain melittin signal sequence to generate
plasmid pKH74, which encodes HCMV gB706. To generate gB706 with a C-terminal His6
tag, PCR product was generated using forward primer 5′-
CGCGCGCATATGAAAAATACGGAAACGTGTC-3′, NdeI site underlined, reverse
primer 5′-
CGCAAGCTTTCAATGGTGATGGTGATGGTGGGTACCGGGCGGTAGCGGGTCGAC
TA-3′, HindIII site underlined, and pKH74 plasmid as a template. This product was
subcloned into the NdeI and HindIII-digested pKH74 plasmid yielding plasmid pKH75
encoding gB706-CHis6. To generate gB706 with an N-terminal His6 tag, PCR product was
generated using forward primer 5′-
CGCGGATCCGCACCATCACCATCACCATGGTACTAGTTCTTCTAGTACTTCCCAT
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GC-3′, BamHI site underlined, reverse primer 5′-
CGCGCGCATATGTTTGATTGTATGAAGTATTG-3′, NdeI site underlined, and pKH74
plasmid as a template. This product was subcloned into the BamHI and NdeI-digested
pKH74 plasmid yielding plasmid pKH76 encoding gB706-NHis6.
To generate the quadruple mutant gB ectodomain, Y155G/I156H/Y157R/W240A
(gB706-4M), mutation W240A was first introduced into pKH74 plasmid by site-directed
mutagenesis using forward primer 5′-GGCAGCACCGCGCTCTATCGTGAGACCTGT-3′
and reverse primer 5′-ACAGGTCTCACGATAGAGCGCGGTGCTGCC-3′, generating
plasmid pSS1. Three mutations Y155G/I156H/Y157R were then introduced simultaneously
by splicing-by-overlap-extension PCR (SOE-PCR) method. Forward primer 5′-
CGGTCTAGAACCATGAAATTCTT-3′, XbaI site underlined, and reverse primer 5′-
GCAGATAAGTGGTGCGGTGGCCAGCGTAGCTACG-3′ were used to generate the 5′
SOE PCR fragment. Forward primer 5′-
CGTAGCTACGCTGGCCACCGCACCACTTATCTGC-3′ and reverse primer 5′-
CGCGCATATGTTTGATTGTAT-3′, NdeI site underlined, were used to generate the 3′
SOE PCR fragment. The resulting PCR product was subcloned into XbaI and NdeI-digested
plasmid pSS1 to yield plasmid pSS2 encoding HCMV gB706-4M mutant.
All clones were sequenced and verified to contain the correct reading frame and appropriate
sequences. Due to the cloning strategy, all mature proteins contain two extra residues (DP)
at the N terminus. The His6 tag was left out from the gB706-4M construct because it was not
necessary for immunoaffinity purification.
The full-length HCMV gB-4M mutant was generated by the SOE-PCR method using the
entire HCMV gB (strain TR) gene as a template. Three PCR fragments were made
separately using three primer pairs: 5′-





AAAAAACTCGAGTCAGACGTTCTCTTCTTCGTCAGAG-3′ (XhoI site underlined).
The three PCR fragments were spliced together, and the resulting PCR product was
subcloned into XbaI and XhoI-digested pCAGGS vector to yield plasmid pSS3 encoding
HCMV TR gB-4M mutant, Y156G/I157H/H158R/W241A. The plasmid also has an
additional, unintended, mutation E610G. gB-4M sequence was then excised from the pSS3
plasmid and inserted into plasmid pCMV-SPORT6 (Invitrogen).
Antibodies
Hybridoma cell lines expressing anti-HCMV gB monoclonal antibodies 27–39 or 27–156
were a gift from William J. Britt (University of Alabama). The monoclonal antibodies were
purified at the GRASP facility at Tufts Medical Center. 27–39 is a conformational mAb that
recognizes the oligomeric form of HCMV gB ectodomain (Britt and Vugler, 1992). 27–156
recognizes antigenic domain 1 (AD-1) (Spaete et al., 1988), the dominant antibody-binding
site within HCMV gB that maps to residues 552–635 (Wagner et al., 1992).
Viruses and cells
Spodoptera frugiperda (Sf9) cells were grown in SF-900 II SFM (Invitrogen) in suspension
at 27ºC. Trichoplasia Ni (HiFive) cells were grown in Express Five SFM (Invitrogen).
Recombinant baculoviruses of all HCMV gB ectodomain constructs were generated using
Bac-to-Bac technology (Invitrogen). After two rounds of amplification, passage 3 (P3)
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stocks of baculoviruses were harvested and stored at 4ºC in the dark and in the presence of
2% Fetal Bovine Serum (FBS, Invitrogen). Human retinal pigmented epithelial (ARPE-19)
cells were obtained from ATCC and grown in DMEM/F-12 medium (Hyclone) in the
presence of 10% FBS (Hyclone). Human dermal fibroblasts (HDFn, Invitrogen) were grown
in DMEM (HyClone) containing 10% FBS, 5% Bovine Growth Serum Supplemented Calf
(HyClone), 3mM glutamine, and Pen/Strep. 911 retinoblastoma cells were maintained in
DMEM containing 10% FBS and Pen/Strep.
Protein expression and purification
For protein expression, P3 stocks of baculoviruses were used to infect Sf9 or Hi5 cells. The
amount of viral inoculum was optimized to yield the highest protein expression. Both Sf9
and Hi5 cells were tested, but Sf9 cells yielded a higher expression of all constructs and
were used for all subsequent expression. Typically, 10 mL of viral stock was added to 1 L of
SF9 cells at 2×106 cells/mL, and cell supernatants were harvested 72 hours post-infection.
Cells were pelleted using centrifugation at 3750 rpm at 4ºC for 20 minutes. The supernatant
was collected, filtered through a 0.45 um filter, and concentrated using a Tangential Flow
Filtration system (Millipore) using a 30-kDa PLTK cartridge (Millipore). Buffer exchange
was done three times into phosphate-buffered saline, pH 7.4, to remove media components.
1 mM benzamidine and 0.1 mM PMSF were added to the extract to inhibit proteolytic
activity.
The gB ectodomain constructs, gB706-CHis6, gB706-NHis6, and the gB706-4M mutant
were purified using immunoaffinity chromatography using monoclonal antibody 27–39
coupled to a CNBr-activated Sepharose 4B (GE Healthcare). After extensive washing with
10 mM Tris (pH 8.0) and 500 mM NaCl, the protein was eluted with 3M KSCN and
concentrated on an Amicon Ultra-15 concentrator (Millipore) with a 30-kDa MW cutoff.
The protein was further purified by size-exclusion chromatography using Superdex S200
column (GE Healthcare) equilibrated with 20 mM Tris (pH 8.0), 150 mM NaCl, and 1 mM
EDTA. The column was calibrated using blue dextran (~2000 kDa), thyroglobulin (667
kDa), ferritin (440 kDa), catalase (232 kDa), and aldolase (158 kDa). The final yield of
gB706-CHis6 and gB706-4M was ~10–20 μg and ~500 μg, respectively, from 1 L of insect
cell supernatant.
HSV-1 gB730 was purified as described previously (Heldwein et al., 2006; Stampfer et al.,
2010).
SDS-PAGE and Western blot
Three conditions were used in preparation of samples for SDS-PAGE: mildly denaturing
(0.1% SDS, no reducing agent, no boiling), non-reducing denaturing (1% SDS, no reducing
agent, boiling), and reducing denaturing (1% SDS, reducing agent, boiling).
For Western blot, proteins were resolved by SDS-PAGE (4–15% acrylamide gel, Bio-Rad)
and transferred onto nitrocellulose membrane. The membrane was blocked with 5%
skimmed milk in Tris-buffered saline containing 0.05% Tween-20 and probed with mAb
27–156 at 1:1000 dilution. Following incubation with secondary antibody, anti-mouse IgG
conjugated to horseradish peroxidase, at a 1:10,000 dilution, and blots were developed using
HRP substrate chemiluminescence kit (Bio-Rad).
Electron microscopy
Purified protein samples of gB706-CHis6 and gB706-4M constructs (5 μg/mL) were
incubated on glow-discharged formvar/carbon-coated 200 mesh copper grids (SPI) at room
Sharma et al. Page 10










temperature and stained with 0.75% solution of uranyl formate. EM images were obtained
using a Tecnai G2 Spirit BioTWIN transmission electron microscope at the Harvard Medical
School EM core facility.
N-terminal sequencing
For N-terminal sequencing, protein samples were resolved by a 4–15% SDS-PAGE and
transferred to a PVDF membrane. The membrane was stained with Coomassie R-250. The
protein bands of interest were cut out and submitted for sequencing by Edman degradation
at the Tufts University Core Facility.
Mass Spectrometry
For mass spectrometry analysis, the HSV-1 gB730 and HCMV gB706-4M proteins were
analyzed using sinapinic acid (Agilent Technologies, US) as matrix. MS measurements were
performed on a Voyager DE-Pro MALDI-TOF Mass Spectrometer (Applied Biosystems).
Size-exclusion chromatography (SEC)-coupled multiangle light scattering (MALS)
For SEC-coupled MALS, the HSV-1 gB730 and HCMV gB706-4M proteins (~2.6 mg/mL
and ~1.5 g/mL injected concentration) were subjected to SEC using Superose 6 column (GE
Healthcare) equilibrated overnight in 20 mM Tris (pH 8.0), 300 mM NaCl, and 1 mM
EDTA. The chromatography system connected in line to a DAWN Heleos II light-scattering
instrument equipped with a 658 nm laser, and Optilab T-rEX interferometric refractometer
(Wyatt Technology). Data were analyzed with ASTRA 6 software (Wyatt Technology),
yielding the molar mass and mass distribution (polydispersity) of the sample. Due to
glycosylation, the data were analyzed using the protein conjugate analysis option within
ASTRA 6 software. To account for glycosylation, the dn/dc value of 0.13 mL/g was used
instead of 0.185 mL/g, which is used for unmodified proteins. For normalization of the light
scattering detectors and data quality control, monomeric BSA was used.
Homology model generation
Homology model of HCMV gB ectodomain, gB706, was generated using standard protocols
in the Modeller software (Eswar et al., 2006) and the crystal structure of HSV-1 gB
ectodomain, gB730 (PDB ID 2GUM) as the template.
Preparation of recombinant replication-defective adenovirus
HCMV TR gB-4M in pCMV-SPORT6 was used for BP-mediated recombination
(Invitrogen) with the Adeno-X-ccdB bacterial artificial chromosome (BAC) according to
manufacturer’s instructions. After in-vitro recombination, BAC DNA was electroporated
into DH10B bacterial cells, and bacteria selected using chloramphenicol and ampicillin.
Individual bacterial colonies were screened for the presence of recombinant sequences by
restriction analysis of extracted BAC DNA with BsrGI. Purified BAC DNA was linearized
with PacI (New England Biolabs), and the resulting adenovirus vector encoding HCMV TR
gB-4M was transfected into 911 retinoblastoma cells using calcium phosphate method.
Transfected cells were monitored for 4–6 days for the presence of adenovirus-induced
cytopathic effect, at which point cells were harvested and sonicated to obtain total cell
lysates containing infectious adenovirus. The recombinant adenovirus encoding HCMV TR
gB-4M was titered on 911 retinoblastoma cells as described previously (Vanarsdall et al.,
2008).
Cell-cell fusion assay
ARPE-19 cells were infected with recombinant adenoviruses encoding HCMV TR gH, gL,
and either WT gB or gB-4M mutant at 30 PFU/cell in growth media containing 2% FBS.
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Cells were concomitantly infected with a recombinant adenovirus supplying the Tet
transactivator, required to activate protein expression, at one-fifth of the total PFU. At 4 h
post infection, virus was removed and cells washed twice with growth media, then incubated
in growth media at 37°C for additional 24–60 h. To assess the level of fusion, cells were
fixed in PBS containing 2% formaldehyde, permeabilised with PBS containing 0.2% Triton
X-100, and stained with a 5 μm stock of SYTO 13 green fluorescent nucleic acid stain
(Invitrogen) diluted 1:20,000 in PBS. Images were captured on Nikon Eclipse TS100
microscope fitted with a Qiacam digital CCD camera. The level of fusion was quantified by
counting the total number of cell nuclei in syncytia divided by the total number of nuclei in
the same field and expressed as the percentage of cells fused. A syncytium was defined as
such when one fluorescent membrane enclosed 10 or more nuclei.
Cell-based ELISA assay
HDFn cells were seeded at 2×104 cells per well of a 96 well plate. The following day, cells
were infected with adenoviral vector encoding WT gB or gB-4M mutant at 100 pfu/cell in
media containing 2% FBS. 6 h post infection, the cells were washed twice and low serum
media was replaced. 48 h post infection, mAb 27–156 was added to the cells in media
containing 2% donkey serum at 4°C. Cells were incubated with the antibody for 2 h at 4°C,
washed extensively with cold PBS +/+, then fixed with 4% PFA in PBS+/+ for 1 hr at 4°C.
After rehydration in PBS+/+, the samples were incubated with donkey anti-mouse HRP
(Jackson ImmunoResearch) for 30 min at RT, washed, and TMB substrate (Sigma) was
added. Reaction was stopped with the addition of 2M H2SO4 and plates read in a
SpectraMAX190 (Molecular Devices) at 450 nm.
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Schematic view of the full-length HCMV gB and constructs used in this work. SS – signal
sequence, MP – membrane-proximal region, TM – transmembrane region, Cyto –
cytoplasmic domain. 18 predicted N-linked glycosylation sites are shown as lollipops.
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Properties of the HCMV gB706-CHis6. (A). Coomassie-stained gels and a Western blot of
purified HCMV gB706-CHis6. Under non-reducing mildly denaturing conditions (-BME,
unboiled), the protein migrates as a mixture of monomer and trimer. Under reducing
denaturing conditions (+BME, boiled), some protein migrates as an intact monomer while a
fraction separates into the N-terminal and C-terminal fragments. O – oligomer, M –
monomer, N – N-terminal fragment, C – C-terminal fragment. Molecular size standards are
labeled. (B). Size-exclusion chromatogram of purified gB706-CHis6. gB elutes as a broad
peak near the void volume. The elution volumes of the void and the 667 kDa standard are
shown (arrows). (C). Electron micrograph of purified gB706-CHis6. Arrows indicate long
rods (D, dimer of trimers) and three-armed particles (T, trimer of trimers). Close-up view of
selected rods and three-armed particles is shown below. Pink asterisks mark crown ends.
(D). Electron micrograph of HSV-1 gB730 along with its crystal structure, in surface
representation. Pink asterisks mark crown ends, and blue asterisks mark fusion-loop-
containing base ends.
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Sequence alignment of gB proteins from HSV-1 (strain KOS), EBV (strain B958), and
HCMV (strain AD169), generated using ClustalW2 (Larkin et al., 2007). Residue numbers
for HSV-1 gB and HCMV gB are shown above and below their respective sequences.
Secondary structure of HSV-1 gB is shown above the sequence alignment, and its coloring
matches that in reference (Heldwein et al., 2006). Signal sequences, absent from mature
glycoproteins, are shown in red. Identical residues are highlighted in yellow; similar
residues, in grey; cysteines, in green; and putatively glycosylated asparagines, in blue. Furin
cleavage sites in HCMV and EBV are highlighted in purple. Residues in two fusion loop
regions are shown in teal. Figure was generated in ALSCRIPT (Barton, 1993).
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Fusion loop regions in HCMV gB and HSV-1 gB ectodomains. (A). Crystal structure of
HSV-1 gB ectodomain, gB730, is shown side-by-side with a homology model of HCMV gB
ectodomain, gB706, in surface representations. Fusion loop regions are shown in side and
face-on views. Hydrophobic residues (yellow), positively charged residues (blue),
negatively charged residues (red) and histidines (cyan) are shown. Side chains of mutated
residues in HCMV gB706-4M mutant and their HSV-1 counterparts are labeled (in one
protomer only, for clarity). Figures were generated using PyMol (www.pymol.org). (B).
Sequence alignment of the fusion loop regions in HCMV gB, HCMV gB706-4M mutant,
HSV-1 gB, and EBV gB. Hydrophobic residues (orange), positively charged residues (blue),
negatively charged residues (red), and histidines (cyan) are colored. Mutated residues in
HCMV gB and their HSV-1 gB counterparts are underlined.
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Properties of the quadruple mutant gB706-4M. (A). Coomassie-stained gel of purified
gB706-4M. Under non-reducing mildly denaturing conditions (-BME, unboiled), the protein
migrates as a mixture of monomer and trimer. Under non-reducing denaturing conditions (-
BME, boiled), the protein migrates as a monomer. Under reducing denaturing conditions
(+BME, boiled), some protein migrates as an intact monomer while a fraction separates into
the N-terminal and C-terminal fragments. O – oligomer, M – monomer, N – N-terminal
fragment, C – C-terminal fragment. Molecular size standards are labeled. (B). Overlay of
size-exclusion chromatograms of wt HCMV gB706-CHis6, HCMV gB706-4M mutant, and
HSV-1 gB730. The elution volumes of the void and the 667 kDa and 232 kDa standards are
marked with arrows. (C). Electron micrographs of peaks 1 and 2 with different particles
marked with arrows: long rods (D, dimer of trimers), three-armed particles (T, trimer of
trimers), and a single short rod (M, monodisperse trimer). (D) Close-up views of individual
particles in HCMV gB706-4M, peak 2 and HSV-1 gB730. The crystal structure of HSV-1
gB730 in surface representation is shown for comparison. Pink asterisks mark crown ends,
and blue asterisks mark fusion-loop containing base ends.
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gB-4M mutant does not mediate cell fusion despite adequate surface expression. (A) SYTO
13 green fluorescent nucleic acid staining was used to quantify fusion of ARPE-19 cells
mediated by either WT gB or gB-4M mutant, in the presence of gH/gL. The level of fusion
was quantified by counting the total number of cell nuclei in syncytia divided by the total
number of nuclei in the same field and expressed as the percentage of cells fused. A
syncytium was defined as such when membrane enclosed 10 or more nuclei. Reported
values represent an average of three experiments. (B) Surface expression in HDFn cells of
WT gB and gB-4M mutant was assessed by cell-based ELISA with the mAb 27–156. Non-
specific binding of the antibody to cells was measured with cells infected with recombinant
adenovirus encoding Tet transactivator instead of gB. In each experiment, the Tet
transactivator control was subtracted from the sample. Six replicate samples were averaged,
and the signal was expressed as a percentage of WT (100%). Error bars represent standard
deviations. Relatively large standard deviations are likely due to the fact that at any time,
only a small fraction of total HCMV gB is present on the cell surface, especially when
compared to HSV gB or HCMV gB lacking the endocytic motif within the cytoplasmic
domain (data not shown).
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HCMVgB706-4M is a trimer in solution. SEC-coupled multi-angle light scattering (MALS)
analysis of HSV-1 gB730 (A) and HCMV gB706-4M (B) is shown. The signal from the
90°-scattering detector is shown in black and the signal from the refractive index detector is
shown in red; both are plotted against the left Y-axis. Average molecular weights are plotted
in blue against the right Y-axis. Molecular weight corresponding to that of a trimer is shown
as a horizontal dashed black line.
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